
Milestone Scientific fell 18.4% from $0.38 to $0.31, behind the S&P 500's +12.7%. Its worst day was Mar 20 (−15.6%), and its low came Mar 20 at $0.25.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.01 beat the $-0.01 estimate on $2.4M revenue (est. $2.3M).
−13.1% · S&P 500 0.0%
Milestone Scientific closed at its lowest level of the year, 35.1% below where the year started.
Story events cover the past 12 months · Times ET
−15.6%, the year's worst day · S&P 500 −1.4%
EPS of $-0.02 missed the $-0.01 estimate on $2.1M revenue (est. $2.3M); FY revenue guidance of $9.8M–$10.2M against the $9.9M consensus.
+3.7% · S&P 500 +0.8%
EPS of $-0.01 beat the $-0.01 estimate on $2.2M revenue (est. $2.3M); FY revenue guidance of $9.8M–$10.2M against the $9.9M consensus.
−4.3% · S&P 500 +0.8%
EPS of $-0.01 beat the $-0.01 estimate on $2.8M revenue (est. $2.7M); Q3 revenue guidance of $2.3M–$2.5M against the $2.5M consensus.
−10.5% · S&P 500 −0.2%
Where it ended: a close of $0.31 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $-0.01, revenue est. $2.5M).
Nothing in the past 12 months.
All MLSS dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MLSS and SPY from Benzinga historical bars. Not investment advice.